Mayo Clinic Study: Blood Biomarker Could Mark Severe Cognitive Decline, Hasten Progression Among Parkinson’s Patients
The Mayo Clinic lab is researching blood-based biomarkers for Parkinson’s disease because blood tests are less invasive and cheaper than a brain scan or spinal tap, other tools used to research the disease.
Read More